| 000 | 01702 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517041851.0 | ||
| 264 | 0 | _c20160922 | |
| 008 | 201609s 0 0 eng d | ||
| 022 | _a2042-6313 | ||
| 024 | 7 |
_a10.2217/cer.15.33 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSignorovitch, James E | |
| 245 | 0 | 0 |
_aComparative efficacy and safety of daclatasvir/asunaprevir versus IFN-based regimens in genotype 1b hepatitis C virus infection. _h[electronic resource] |
| 260 |
_bJournal of comparative effectiveness research _cNov 2015 |
||
| 300 |
_a593-605 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCarbamates |
| 650 | 0 | 4 | _aComparative Effectiveness Research |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepacivirus _xdrug effects |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xadministration & dosage |
| 650 | 0 | 4 |
_aInterferons _xadministration & dosage |
| 650 | 0 | 4 |
_aIsoquinolines _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPyrrolidines |
| 650 | 0 | 4 |
_aRibavirin _xadministration & dosage |
| 650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
| 650 | 0 | 4 |
_aValine _xanalogs & derivatives |
| 700 | 1 | _aBetts, Keith A | |
| 700 | 1 | _aSong, Yan | |
| 700 | 1 | _aSorg, Rachael A | |
| 700 | 1 | _aLi, Junlong | |
| 700 | 1 | _aBehl, Ajay S | |
| 700 | 1 | _aKalsekar, Anupama | |
| 773 | 0 |
_tJournal of comparative effectiveness research _gvol. 4 _gno. 6 _gp. 593-605 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2217/cer.15.33 _zAvailable from publisher's website |
| 999 |
_c25059439 _d25059439 |
||